The result was delete. Rlendog ( talk) 21:48, 17 February 2012 (UTC) reply
Small Indian biochemical firm; the article previously claimed to be partnered with Siena Biotech (an Italian firm) and GlaxoSmithKline, but these claims seem to have been either misleading or entirely unsupported by the sources. The one remaining claim of involvement with a major partner is sourced to a press release from the company, which bears an astonishing similarity to this press release from the other Siena Biotech, here, with the names changed; the supposed partner, Omega, didn't issue a press release on their own site, and so I have real doubts about this claim.
If these claims are removed, we have a relatively small firm (revenues of 82M Rs. ~ 1M GPB, 1.5M USD) with no external sources provided to show its importance. The notability guidelines explicitly require significant coverage in secondary sources, and that simply isn't provided here. I've made some efforts to find any, but it's almost impossible to find anything about the firm that doesn't turn out to be discussing the Italian company. Shimgray | talk | 16:08, 10 February 2012 (UTC) reply